Prostate cancer blood test research study
Part of Cancer, Kidney & urinary clinical trials.
This study is looking at blood samples from people with prostate cancer to better understand the disease. It may help researchers find new ways to monitor or treat prostate cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of prostate cancer.
- You must be eligible to receive drug treatment for prostate cancer.
- You must agree to take part in the study and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial collects blood samples from adults with prostate cancer. It may help researchers learn more about the disease or how treatments work, without directly testing a new drug in the eligibility you provided.
This study analyzes tumor tissue and blood samples from men with advanced prostate cancer to understand genetic changes that may affect treatment choices. Results may help doctors personalize your treatment plan.
This study looks at using a simple blood test (liquid biopsy) to read tumor DNA and understand how it could affect treatment decisions. It is for adults with metastatic prostate cancer who are about to start, are receiving, or recently finished treatment.
This trial studies a blood test that looks for tumor DNA in men with high-risk or advanced prostate cancer. It may help doctors understand the cancer better and guide treatment decisions.
This study explores whether a simple blood test that looks at tiny particles called exosomes can help diagnose prostate cancer, possibly reducing the need for biopsies. If you have higher PSA levels and are scheduled for a biopsy, this trial might be a fit.
This trial tests a new way to find genetic changes in metastatic prostate cancer using a blood test (liquid biopsy) when tumor tissue is not available. It may help doctors choose better treatments for you.
Hear when a new Metastatic Prostate Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.